linkedin post 2013-11-20 06:29:11
$2.1 BILLION PHARMA SETTLEMENT. Teva and Sun Pharma will pay $2.15 billion to settle a patent suit related to its acid-reflux drug. "This is the first instance of generic drugmakers paying damages for marketing a copy of an existing drug for which patents have yet to expire (an 'at-risk' launch)." ""It is an important milestone, setting a 'book-end' case for the industry. It will serve to encourage patent settlements," " " http://lnkd.in/dHi9MEX View in LinkedIn